Congratulations to Taiyin Yang, EVP, for Being Elected to the 2022 Class of the National Academy of Engineering.
Election to the NAE is among the highest professional distinctions in the field, and we're very proud.
Congratulations to Taiyin Yang, EVP, Pharmaceutical Development and Manufacturing, for being elected to the 2022 class of the National Academy of Engineering. Taiyin, who was one of the first scientists to join Gilead and helped grow our company into a global organization, was honored for her work on the invention, production and global distribution of single tablet regimens for treating HIV. Election to the NAE is among the highest professional distinctions in the field, and we're very proud.
About Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
Originally published by Gilead Sciences. View original content here.
At Gilead, we’re committed to creating a healthier world for everyone – no matter the challenges ahead of us. For more than 30 years, we’ve pursued the impossible, chased it down, tackled it for answers and surrounded it for a way in. We have worked tirelessly to bring forward medicines for life-threatening diseases.
Through bold and transformative science, we’re driving innovation that has the potential to become the next generation of life-changing medicines. Our ambition is evident in our mission. Because the impossible is not impossible. It’s what’s next.
